EC-NAPROSYN

This brand name is authorized in United Kingdom, United States

Active ingredients

The drug EC-NAPROSYN contains one active pharmaceutical ingredient (API):

1 Naproxen
UNII 57Y76R9ATQ - NAPROXEN

Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis.

Read about Naproxen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NAPROSYN, EC-NAPROSYN, ANAPROX DS Tablet, Delayed-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AE02 Naproxen M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 18474, 18493, 18521
Country: US FDA, National Drug Code Identifier(s): 69437-415, 69437-416

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.